Abstract

BackgroundEarly prediction of oxygen therapy in patients with coronavirus disease 2019 (COVID-19) is vital for triage. Several machine-learning prognostic models for COVID-19 are currently available. However, external validation of these models has rarely been performed. Therefore, most reported predictive performance is optimistic and has a high risk of bias. This study aimed to develop and validate a model that predicts oxygen therapy needs in the early stages of COVID-19 using a sizable multicenter dataset.MethodsThis multicenter retrospective study included consecutive COVID-19 hospitalized patients confirmed by a reverse transcription chain reaction in 11 medical institutions in Fukui, Japan. We developed and validated seven machine-learning models (e.g., penalized logistic regression model) using routinely collected data (e.g., demographics, simple blood test). The primary outcome was the need for oxygen therapy (≥1 L/min or SpO2 ≤ 94%) during hospitalization. C-statistics, calibration slope, and association measures (e.g., sensitivity) evaluated the performance of the model using the test set (randomly selected 20% of data for internal validation). Among these seven models, the machine-learning model that showed the best performance was re-evaluated using an external dataset. We compared the model performances using the A-DROP criteria (modified version of CURB-65) as a conventional method.ResultsOf the 396 patients with COVID-19 for the model development, 102 patients (26%) required oxygen therapy during hospitalization. For internal validation, machine-learning models, except for the k-point nearest neighbor, had a higher discrimination ability than the A-DORP criteria (P < 0.01). The XGboost had the highest c-statistic in the internal validation (0.92 vs. 0.69 in A-DROP criteria; P < 0.001). For the external validation with 728 temporal independent datasets (106 patients [15%] required oxygen therapy), the XG boost model had a higher c-statistic (0.88 vs. 0.69 in A-DROP criteria; P < 0.001).ConclusionsMachine-learning models demonstrated a more significant performance in predicting the need for oxygen therapy in the early stages of COVID-19.

Highlights

  • The novel coronavirus disease 2019 (COVID-19), first reported in the Hubei province of the People’s Republic of China in December 2019, has led to an urgent threat to global health

  • We retrospectively studied all consecutive patients with COVID-19 confirmed by reverse transcription-polymerase chain reaction (RT-PCR) using a pharyngeal swab test for model development and internal validation admitted to participating medical facilities

  • The present study aimed to develop and validate a machine-learning model to identify COVID-19 patients who are mildly ill at the time of initial diagnosis and who require oxygen therapy during the course of their illness

Read more

Summary

Introduction

The novel coronavirus disease 2019 (COVID-19), first reported in the Hubei province of the People’s Republic of China in December 2019, has led to an urgent threat to global health. Some asymptomatic or patients with mild symptoms of COVID-19 at the first medical visit develop severe pneumonia during observation [5, 6]. Accurate medical triage for asymptomatic patients and patients with mild symptoms in the early stage of COVID-19 is essential to decrease the incidence of death and allocate limited medical resources appropriately during the observation period [11]. Most published models have not been externally validated with calibration plots, resulting in a high risk of bias [13–15]. Prediction of oxygen therapy in patients with coronavirus disease 2019 (COVID-19) is vital for triage. Most reported predictive performance is optimistic and has a high risk of bias. This study aimed to develop and validate a model that predicts oxygen therapy needs in the early stages of COVID-19 using a sizable multicenter dataset

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call